1. Supportive and palliative care in hemato-oncology: how best to achieve seamless integration and subspecialty development?

   • Hon Wai Benjamin Cheng
   • Ka On Lam

   Review Article 03 January 2021 Pages: 601 - 606

   

2. Erythrocyte microRNAs: a tiny magic bullet with great potential for sickle cell disease therapy

   • Henu Kumar Verma
   • Yashwant Kumar Ratre
   • Raffaella Colombatti

   Review Article 04 January 2021 Pages: 607 - 614

   

3. Skin changes in hairy cell leukemia

   • Ewa Robak
   • Dorota Jesionek-Kupnicka
   • Tadeusz Robak

   Review Article Open access 20 November 2020 Pages: 615 - 625

   

4. The effect of curcumin on serum copper, zinc, and zinc/copper ratio in patients with β-thalassemia intermedia: a randomized double-blind clinical trial

   • Mohammadreza Saeidnia
   • Peyman Nowrouzi-Sohrabi
   • Mehran Karimi

   Original Article 12 January 2021 Pages: 627 - 633

   

5. Effects of three months of treatment with vitamin E and N-acetyl cysteine on the oxidative balance in patients with transfusion-dependent β-thalassemia

   • Sezaneh Haghpanah
   • Nader Cohan
   • Omid Reza Zekavat

   Original Article 20 November 2020 Pages: 635 - 644

   

6. Risk factors and predictors of treatment responses and complications in immune thrombocytopenia

   • Shin Yeu Ong
   • Chuen Wen Tan
   • Lai Heng Lee

   Original Article 30 January 2021 Pages: 645 - 651

   

7. Antimicrobial prophylaxis in patients with immune thrombocytopenia treated with rituximab: a retrospective multicenter analysis

   • Simona Raso
   • Mariasanta Napolitano
   • Sergio Siragusa

   Original Article 26 January 2021 Pages: 653 - 659

8. Correction of iron deficiency in hospitalized heart failure patients does not improve patient outcomes

   • Ronak H. Mistry
   • Andrew Kohut
   • Patricia Ford

   Original Article 09 November 2020 Pages: 661 - 666

9. G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?

   • Jihad G. Youssef
   • Faisal Zahiruddin
   • Swaminathan P. Iyer

   Original Article 13 January 2021 Pages: 667 - 673

   

10. Hematologic changes predict clinical outcome in recovered patients with COVID-19

    • Jian Mao
    • Rong Dai
    • Xiao-Hua Luo

    Original Article 01 February 2021 Pages: 675 - 689

    

11. Nivolumab discontinuation and retreatment in patients with relapsed or refractory Hodgkin lymphoma

    • Liudmila V. Fedorova
    • Kirill V. Lepik
    • Boris V. Afanasyev

    Original Article 02 February 2021 Pages: 691 - 698

    

12. Acute lymphoblastic leukemia–like treatment regimen provides better response in mixed phenotype acute leukemia: a comparative study between adults and pediatric MPAL patients

    • Eman O. Rasekh
    • Randa Osman
    • Sally Elfishawi

    Original Article 23 November 2020 Pages: 699 - 707

    

13. Watch-and-wait or immediate immunotherapy/immunochemotherapy in patients with phase IE primary pulmonary MALT lymphoma? A multicenter retrospective study

    • Wei Yan
    • Bin Wu
    • Hui-Han Wang

    Original Article 22 January 2021 Pages: 709 - 714

    

14. Novel tumour–infiltrating lymphocyte-related risk stratification based by flow cytometry for patients with de novo angioimmunoblastic T cell lymphoma

    • Qiqi Zhu
    • Xueqin Deng
    • Sha Zhao

    Original Article 02 January 2021 Pages: 715 - 723

    

15. Treatment of relapsed/refractory multiple myeloma in the bortezomib and lenalidomide era: a systematic review and network meta-analysis

    • Leonardo Javier Arcuri
    • Andre Dias Americo

    Original Article 11 January 2021 Pages: 725 - 734

    

16. Utilization of radiation therapy in multiple myeloma: trends and changes in practice

    • Sikander Ailawadhi
    • Ryan Frank
    • Taimur Sher

    Original Article 12 January 2021 Pages: 735 - 741

    

17. A multicenter phase II study of intrabone single-unit cord blood transplantation without antithymocyte globulin

    • Tetsuya Nishida
    • Takeshi Kobayashi
    • Makoto Murata

    Original Article 11 January 2021 Pages: 743 - 752

    

18. Possible nosocomial transmission of virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation

    • Yoshiyuki Onda
    • Junya Kanda
    • Akifumi Takaori-Kondo

    Original Article 13 January 2021 Pages: 753 - 761

    

19. Impact of donor and recipient Epstein-Barr Virus serostatus on outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis

    • Michalina Kołodziejczak
    • Lidia Gil
    • on behalf of Infectious Diseases Working Party, European Society for Blood and Marrow Transplantation

    Original Article Open access 25 January 2021 Pages: 763 - 777

    

20. Abatacept as salvage therapy in chronic graft-versus-host disease—a retrospective analysis

    • Tobias Wertheimer
    • Marius Dohse
    • Daniel Wolff

    Original Article Open access 30 January 2021 Pages: 779 - 787

    

21. Post-transplant ferritin level predicts outcomes after allogeneic hematopoietic stem cell transplant, independent from pre-transplant ferritin level

    • Warren Fingrut
    • Arjun Law
    • Dennis Dong Hwan Kim

    Original Article 07 January 2021 Pages: 789 - 798

    

22. Haploidentical hematopoietic stem cell transplantation for patients with myeloid sarcoma: a single center retrospective study

    • Wen-Jing Yu
    • Yu-Qian Sun
    • Yu Wang

    Original Article 08 January 2021 Pages: 799 - 808

    

23. Early autologous and allogeneic peripheral blood stem cell transplantation for adult patients with acute B and T cell precursor neoplasms: a 12-year single center experience

    • Normann Steiner
    • L. Brunelli
    • D. Nachbaur

    Original Article Open access 26 January 2021 Pages: 809 - 816

    

24. Venetoclax and donor lymphocyte infusion for early relapsed acute myeloid leukemia after allogeneic hematopoietic cell transplantation. A retrospective multicenter trial

    • Odelia Amit
    • Yael Bar On
    • Ron Ram

    Original Article 13 January 2021 Pages: 817 - 824

    

25. Building a network of TP53 and IGHV testing reference centers across Spain: the Red53 initiative

    • Francesc Bosch
    • Blanca Navarro
    • María José Terol

    Original Article Open access 06 January 2021 Pages: 825 - 830

    

26. A rare cause of respiratory failure in acute myeloid leukaemia patient

    • F. Z. Lahlimi
    • I. Tazi

    Letter to the Editor 14 July 2020 Pages: 831 - 832

    

27. Coombs-negative hemolytic anemia and elevated plasma hemoglobin levels in COVID-19

    • Guido Lancman
    • Bridget K. Marcellino
    • Kevin Troy

    Letter to the Editor 01 August 2020 Pages: 833 - 835

28. Compassionate use of glasdegib in combination with low-dose cytarabine for relapsed, refractory acute myeloid leukemia or high-risk myelodysplastic syndrome

    • Márcio Tavares
    • Sérgio Chacim
    • José Mário Mariz

    Letter to the Editor 01 October 2020 Pages: 837 - 839

29. Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report

    • Hannah Schüller
    • Franziska Klein
    • Eric Peter Prager

    Letter to the Editor Open access 10 November 2020 Pages: 841 - 842

30. COVID-19 infection in patients with multiple myeloma: a German-Chinese experience from Würzburg and Wuhan

    • Xiang Zhou
    • Tao Bai
    • Leo Rasche

    Letter to the Editor Open access 18 July 2020 Pages: 843 - 846

31. Repeated ruptures of corpus luteum in a female patient with alpha1-antitrypsin Pittsburgh

    • Xiao-Hua Luo
    • Yan Zhu
    • Lin Liu

    Letter to the Editor 06 November 2020 Pages: 847 - 850

    

32. Ixazomib and lenalidomide maintenance therapy in multiple myeloma

    • Ricardo D. Parrondo
    • Victoria Alegria
    • Sikander Ailawadhi

    Letter to the Editor 08 November 2020 Pages: 851 - 853